Exozymes, Stock Today
| EXOZ Stock | 10.13 2.48 19.67% |
PerformanceVery Weak
| Odds Of DistressLow
|
EXoZymes, is trading at 10.13 as of the 28th of March 2025; that is 19.67% down since the beginning of the trading day. The stock's open price was 12.61. EXoZymes, has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. EXoZymes, symbol was changed from IZTC on 12th of February 2025. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
IPO Date 13th of November 2024 | Category Healthcare |
EXoZymes, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 9.53 M outstanding shares of which 24.15 K shares are currently shorted by private and institutional investors with about 0.6 trading days to cover. More on eXoZymes,
EXoZymes, Stock Highlights
| Older Symbol | IZTC |
| Chairman CoFounder | Mohammad JD |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, NASDAQ Health Care, Biotechnology, Healthcare (View all Sectors) |
eXoZymes, (EXOZ) is traded on NASDAQ Exchange in USA. It is located in 750 Royal Oaks Drive, Monrovia, CA, United States, 91016 and employs 29 people. eXoZymes, was previously known as Invizyne Technologies Common and was traded on NASDAQ Exchange under the symbol IZTC. EXoZymes, is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 185.05 M. eXoZymes, conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 9.53 M outstanding shares of which 24.15 K shares are currently shorted by private and institutional investors with about 0.6 trading days to cover.
EXoZymes, generates negative cash flow from operations
Check EXoZymes, Probability Of Bankruptcy
Ownership AllocationThe market capitalization of eXoZymes, is USD185.05 Million. eXoZymes, shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.33 percent of eXoZymes, outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check EXoZymes, Ownership Details
EXoZymes, Historical Income Statement
EXoZymes, Stock Against Markets
EXoZymes, Corporate Executives
Elected by the shareholders, the EXoZymes,'s board of directors comprises two types of representatives: EXoZymes, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EXoZymes,. The board's role is to monitor EXoZymes,'s management team and ensure that shareholders' interests are well served. EXoZymes,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EXoZymes,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tyler Korman | CoFounder Research | Profile | |
| Paul Opgenorth | CoFounder Development | Profile |
Additional Tools for EXoZymes, Stock Analysis
When running EXoZymes,'s price analysis, check to measure EXoZymes,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXoZymes, is operating at the current time. Most of EXoZymes,'s value examination focuses on studying past and present price action to predict the probability of EXoZymes,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXoZymes,'s price. Additionally, you may evaluate how the addition of EXoZymes, to your portfolios can decrease your overall portfolio volatility.